We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Technopath Clinical Diagnostics

Download Mobile App


ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.
23 Sep 2021 - 25 Sep 2021

Redox Potential Used as a Feasible Marker for Banked Blood Quality

By LabMedica International staff writers
Posted on 09 Sep 2021
Print article
Image: The Princeton Applied Research ParstatMC multi-potentiostat was used to identify redox potential as a feasible marker for banked blood quality (Photo courtesy of Ametek)
Image: The Princeton Applied Research ParstatMC multi-potentiostat was used to identify redox potential as a feasible marker for banked blood quality (Photo courtesy of Ametek)
Stored red blood cells (RBCs) may undergo oxidative stress over time, with functional changes affecting oxygen delivery. Central to these changes are oxidation-reduction (redox) reactions and redox potential (RP) that must be maintained for cell function.

Despite the seeming importance and implications of utilizing RP measures, there are currently few means by which to make the measurement directly, and most investigators have relied historically on isolated redox species and secondary markers of oxidative stress such as glutathione couples, malondialdehyde, and estimates of oxidative injury in processed samples.

Biomedical Engineers at the University of Michigan (Ann Arbor, MI, USA) investigated changes in RP over time in banked RBCs, and among RBCs of similar age. The scientists tested multiple random RBC segments from RBC units were tested (n = 32), ranging in age from five to 40 days, at 5-day intervals. RP was recorded by measuring open circuit potential of RBCs using nanoporous gold electrodes with Ag/AgCl reference. RP measures were also performed on peripheral venous blood from 10 healthy volunteers. RP measures were compared between RBC groups, and with volunteer blood.

Direct measurement of RP was performed by measuring open circuit potential of the RBC sample via the np gold electrode, with Ag/AgCl reference, using a ParstatMC multi-potentiostat (Princeton Applied Research, Berwyn, PA, USA). The investigators reported that stored RBCs show time-dependent RP increases. There were significant differences in Day 5 RP compared to all other groups, Day 10–15 versus ages ≥ Day 20, Day 20–25 versus Day 40, and all groups compared to healthy volunteers. RP became more positive over time suggesting ongoing oxidation as RBCs age; however, storage time alone was not predictive of RP measured in a particular unit/segment.

The authors concluded that there were significant differences in RP between freshly stored RBCs and all others, with RP becoming more positive over time. However, storage time alone does not predict RP, indicating RP screening may be important independent of age and may serve as a marker of RBC health. Targeting RP may enable the use of antioxidant therapies to restore RP balance in stored RBCs, as well as systemically in those receiving multiple transfusions, improving the clinical effectiveness of RBCs and potentially reducing associated morbidities. The study was published on August 23, 2021 in the Journal of Clinical Laboratory Analysis.

Related Links:
University of Michigan
Princeton Applied Research

Gold Supplier
SARS-CoV-2/Flu A/B & RSV Test
RespiBio Panel 3 (RBRP3)
Silver Supplier
SARS-CoV-2 IgG Antibody Test
Epithod AutoDx SARS-CoV-2 IgG
Urea Breath Test System for H. Pylori
BreathID Hp Lab
Silver Supplier
Automated Nucleic Acid Extractor

Print article



view channel
Image: The CellSearch Circulating Tumor Cell Kit is intended for the enumeration of circulating tumor cells of epithelial origin (CD45-, EpCAM+, and cytokeratins 8, 18+, and/or 19+ and PD-L1) in whole blood (Photo courtesy of CellSearch/Menarini Silicon Biosystems)

PD-L1 Expression in Circulating Tumor Cells Investigated for NSCLC

In non-small cell lung cancer (NSCLC), analysis of programmed cell death ligand 1 (PD-L1) expression in circulating tumor cells (CTCs) is a potential alternative to overcome the problems linked to the... Read more


view channel

Global Digital Polymerase Chain Reaction (dPCR) Market Projected to Reach Close to USD 1.15 Billion by 2028

The global digital polymerase chain reaction (dPCR) market is projected to grow at a CAGR of more than 9% from over USD 0.50 billion in 2020 to nearly USD 1.15 billion by 2028, driven primarily by rising... Read more
Copyright © 2000-2021 Globetech Media. All rights reserved.